Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:45 pm Purchase |
2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 5,199,746 9.990% |
1,689,643 (+48.14%) |
Filing History |
| 2023-02-14 2:35 pm Sale |
2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
PERCEPTIVE ADVISORS LLC | 1,800,000 3.600% |
-350,641 (-16.30%) |
Filing History |
| 2023-02-13 6:02 pm Purchase |
2022-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BIOTECHNOLOGY VALUE FUND L P | 4,917,774 9.990% |
1,321,017 (+36.73%) |
Filing History |
| 2023-02-13 09:25 am Unchanged |
2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE |
Kynam Capital Management, LP | 4,420,349 9.200% |
0 (Unchanged) |
Filing History |
| 2023-02-10 3:51 pm Purchase |
2022-12-30 | 13G | Concert Pharmaceuticals, Inc. CNCE |
Kynam Capital Management, LP | 4,420,349 9.200% |
4,420,349 (New Position) |
Filing History |
| 2022-02-14 4:11 pm Purchase |
2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 3,510,103 9.990% |
1,686,583 (+92.49%) |
Filing History |
| 2022-02-14 3:46 pm Unchanged |
2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
PERCEPTIVE ADVISORS LLC | 2,150,641 6.200% |
0 (Unchanged) |
Filing History |
| 2022-01-13 10:20 am Sale |
2021-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BANK OF AMERICA CORP BAC |
1,007,258 2.900% |
-870,960 (-46.37%) |
Filing History |
| 2021-11-15 4:58 pm Purchase |
2021-11-03 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BIOTECHNOLOGY VALUE FUND L P | 3,596,757 9.990% |
3,596,757 (New Position) |
Filing History |
| 2021-07-12 08:29 am Sale |
2021-06-30 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BLACKROCK INC BLK |
670,035 2.100% |
-1,534,474 (-69.61%) |
Filing History |
| 2021-02-16 4:39 pm Purchase |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
RA Capital Management, L.P. | 1,823,520 5.900% |
1,823,520 (New Position) |
Filing History |
| 2021-02-16 3:30 pm Unchanged |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
PERCEPTIVE ADVISORS LLC | 2,150,641 7.000% |
0 (Unchanged) |
Filing History |
| 2021-02-12 4:38 pm Sale |
2021-02-16 | 13G | Concert Pharmaceuticals, Inc. CNCE |
DIMENSIONAL FUND ADVISORS INC | 1,079,170 3.500% |
-129,831 (-10.74%) |
Filing History |
| 2021-02-09 4:41 pm Sale |
2005-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
INGALLS & SNYDER LLC | 1,396,003 4.550% |
-68,709 (-4.69%) |
Filing History |
| 2021-02-08 5:06 pm Purchase |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BANK OF AMERICA CORP BAC |
1,878,218 6.100% |
67,012 (+3.70%) |
Filing History |
| 2021-02-02 2:56 pm Purchase |
2020-12-31 | 13G | Concert Pharmaceuticals, Inc. CNCE |
BLACKROCK INC BLK |
2,204,509 7.200% |
735,550 (+50.07%) |
Filing History |